News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
STEINMAN LAWRENCE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.55, valued at
$177.5k
|
|
| 06/06/2023 |
4/A
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp. |
| 06/06/2023 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp.|
Txns:
| Bought 30,000 shares
@ $0.431, valued at
$12.9k
|
|
| 06/02/2023 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on 180 Life Sciences Corp.|
Txns:
| Bought 18,000 shares
@ $1.226, valued at
$22.1k
|
|
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp.|
Txns:
| Granted 1,000 shares
@ $1.14, valued at
$1.1k
Granted 9,000 shares
@ $1.13, valued at
$10.2k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.48, valued at
$49.6k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 450 shares
@ $30, valued at
$13.5k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 450 shares
@ $36.82, valued at
$16.6k
|
|
| 09/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/18/2021 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 450 shares
@ $40.6, valued at
$18.3k
|
|
| 07/19/2021 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 450 shares
@ $38.29, valued at
$17.2k
|
|
| 06/16/2021 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Acquired 5,388 shares
@ $0
Granted 12,307 options to buy
@ $39.64, valued at
$487.8k
|
|
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
3
| STEINMAN LAWRENCE (Director) has filed a Form 3 on BioAtla, Inc. |
| 11/12/2020 |
3
| STEINMAN LAWRENCE (Director) has filed a Form 3 on 180 Life Sciences Corp. |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
3
| STEINMAN LAWRENCE (Director) has filed a Form 3 on Atreca, Inc. |
|
|